Rubric Capital Management LP - Jun 30, 2025 SCHEDULE 13G Report for Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)

Filing Manager
Rubric Capital Management LP
Reporting Manager
Rubric Capital Management LP
Security
Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
TRVI
Shares outstanding
120M shares
Disclosed Ownership
8.53M shares
Ownership
7.12%
Form type
SCHEDULE 13G
Date filed
7/9/2025, 04:06 PM
Date of event
Jun 30, 2025
Previous filing
Feb 13, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rubric Capital Management LP 7.12% 8.53M 0 8.53M /s/ Michael Nachmani Michael Nachmani / Chief Operating Officer
David Rosen 7.12% 8.53M 0 8.53M /s/ David Rosen David Rosen, Individually